Drug Topics

JANUARY 17, 2023

Childhood vaccinations took a downturn during the pandemic. Now is the time to get them done and pharmacists can help.

Vaccines 448

Vaccines 448

PhRMA

JANUARY 17, 2023

The Inflation Reduction Act’s (IRA’s) drug price setting provisions, as predicted, are already impacting biopharmaceutical research & development (R&D) decisions. Whether you are looking at estimates of how many fewer medicines or indications will be developed, or noting shifts away from areas of unmet patient need because the law is signaling those innovations are not valued, the IRA’s price setting provisions are a loss for patients everywhere.

297

297

Drug Topics

JANUARY 17, 2023

Moderna’s mRNA-1345 vaccine targets RSV in older adults.

Vaccines 345

Vaccines 345

Pharmacy Times

JANUARY 17, 2023

Vaccination provides an opportunity to prevent and treat herpes simplex virus infection.

Vaccines 167

Vaccines 167

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Drug Topics

JANUARY 17, 2023

A recent study found that the risk of cardiovascular diseases was not significantly greater in patients taking medications for attention-deficit/hyperactivity disorder (ADHD), but investigators were not able to rule out a mild risk increase.

247

247

PharmaVoice

JANUARY 17, 2023

Companies with advanced molecular therapies, oncology assets and obesity treatments could be fuel for a dealmaking fire this year.

163

163

Pharmacy Times

JANUARY 17, 2023

Energy crisis in Europe puts strain on production and could have ramifications that extend beyond the continent's borders.

139

139

Fierce Pharma

JANUARY 17, 2023

CDC probes possible safety risk for Pfizer's new COVID shot, sees no need to change vaccine practices. zbecker. Tue, 01/17/2023 - 11:49.

Vaccines 131

Vaccines 131

Pharmacy Times

JANUARY 17, 2023

An app using AI to evaluate blood sugar data, concerning trends, and recommend management tools will be a part of a clinical trial in 2024 for further assessment.

139

139

PhRMA

JANUARY 17, 2023

Last summer, the United States and Taiwan launched the U.S.-Taiwan Initiative on 21st-Century Trade to deepen economic and trade relations. In detailed comments to the U.S. Trade Representative (USTR), PhRMA encouraged the Biden administration to pursue an agreement that is as comprehensive and ambitious as possible to the benefit of both American and Taiwanese citizens.

130

130

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharmacy Times

JANUARY 17, 2023

Study notes that evaluating changes in the proportion of hospitalizations for mental health conditions among adolescents is vital to ensure the prioritization of public health programs that address psychiatric health care needs that emerged during the COVID-19 pandemic.

Hospitals 132

Hospitals 132

PharmaVoice

JANUARY 17, 2023

Marcus Delatte discusses how and why he focuses his expertise on counseling smaller companies and mentoring the next generation of technical experts.

130

130

Pharmacy Times

JANUARY 17, 2023

COVID-19 infection was significantly associated with increased risks of several conditions, including loss of smell and taste, concentration, and memory impairment.

132

132

The Checkup by Singlecare

JANUARY 17, 2023

When most people hear the word meditation, they probably imagine someone sitting perfectly still in a quiet room, legs crossed, zoned out in a state of total bliss. But meditation can be performed in many different ways, and while it does take some practice to get the hang of it, even just a few minutes a day can help reduce some symptoms of common mental health conditions like anxiety and depression.

Communication 123

Communication 123

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Pharmacy Times

JANUARY 17, 2023

It is too early to know how patients could potentially change their microbiome to reduce their diabetes risk.

132

132

Fierce Healthcare

JANUARY 17, 2023

In a tough fundraising climate for startups, conversations at JPM 2023 shift to partnerships. hlandi. Tue, 01/17/2023 - 16:11.

122

122

Pharmacy Times

JANUARY 17, 2023

The vaccine was 88% effective at preventing pertussis among infants younger than 2 months when administered during the third trimester of pregnancy.

Vaccines 123

Vaccines FDA 123

European Pharmaceutical Review

JANUARY 17, 2023

The Cell and Gene Therapy (CGT) Catapult has published its ‘ UK Advanced Therapy Medicinal Products (ATMP) Clinical Trials Report 2022 ’. In the data, T cells were revealed as the most commonly investigated cell type continuing to increase. The research observed this cell type took up 58 percent of UK ATMP clinical trials in 2022. . Matthew Durdy, Chief Executive of CGT Catapult commented: “It is encouraging to see continued growth of UK clinical trial activity, demonstrating the UK as a favoura

Documentation 119

Documentation 119

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharmacy Times

JANUARY 17, 2023

The scholarship is accepting applications until February 28, 2023, and 4 pharmacy school students will be announced in April.

123

123

STAT

JANUARY 17, 2023

Moderna’s vaccine against the respiratory syncytial virus, or RSV, reduced the rate of lower respiratory disease in people over 60 in a Phase 3 trial, the company said Tuesday. The result will increase competition in a soon-to-be crowded market. The drug giants Pfizer and GlaxoSmithKline have already presented results for their RSV vaccines in older individuals, and have been preparing for what could be a brisk marketing battle.

Vaccines 117

Vaccines 117

Pharmacy Times

JANUARY 17, 2023

The mean annualized bleed rate was reduced by 80% from baseline and Factor VIII usage was reduced by 94% in year 3 compared to baseline.

123

123

Fierce Healthcare

JANUARY 17, 2023

CMS data: Medicare Advantage tops 30M. pminemyer. Tue, 01/17/2023 - 14:45.

111

111

Pharmaceutical Technology

JANUARY 17, 2023

Spain’s Hospital Universitario 12 de Octubre researchers, along with the Josep Carreras Leukaemia Research Institute, have developed a new cell therapy based on STAb cells to treat a type of leukaemia. The Spanish Association Against Cancer (AECC) provided funding for the new STAb therapy development. It could be used for T-Cell Acute Lymphoblastic Leukaemia (T-ALL) treatment in patients for whom bone marrow transplantation and chemotherapy failed to work.

Hospitals 110

Hospitals Chemotherapy Communication Immunization 110

Fierce Healthcare

JANUARY 17, 2023

CMS: More providers serving as ACOs in 2023 amid new reforms and scrutiny. rking. Tue, 01/17/2023 - 14:25.

111

111

STAT

JANUARY 17, 2023

Catherine was getting nervous about her ADHD prescription. In 2022, the 29-year-old New Yorker had started using Done, a direct-to-consumer telehealth company that treats attention deficit hyperactivity disorder. The medication her provider had prescribed, a stimulant called Vyvanse, was helping her manage distraction so severe that she frequently had car accidents.

Controlled Substances 107

Controlled Substances 107

Fierce Healthcare

JANUARY 17, 2023

Providers press CMS to finalize prior authorization reforms to alleviate major administrative burdens. rking. Tue, 01/17/2023 - 17:00.

111

111

Drug Store News

JANUARY 17, 2023

In late December, CVS and Rite Aid instituted product limits as cases of COVID-19, flu and RSV ticked up, amid a scarcity of OTC children’s pain relief products at certain retail locations, including Walgreens.

106

106

Fierce Healthcare

JANUARY 17, 2023

Veterans can get suicide prevention care for free. fdiamond. Tue, 01/17/2023 - 10:20.

105

105

pharmaphorum

JANUARY 17, 2023

UK digital brain health company Cambridge Cognition has bolstered its speech analysis capabilities with the acquisition of Winterlight Labs of Toronto, Canada, in a cash and stock deal worth £7 million ($8.6 million). The deal extends Cambridge Cognition’s technology in the area of the use of voice-based assessments that can be used to detect and monitor health conditions, and according to the company gives it a platform “that can deliver most of the voice tasks used today by psychol

Immunization 105

Immunization 105

STAT

JANUARY 17, 2023

Two congressional committees recently released damning results of an 18-month investigation into the Food and Drug Administration’s approval of Biogen’s controversial Alzheimer’s drug, Aduhelm. The systems that enabled Biogen’s actions, however, went largely unscrutinized. The report listed extensive and serious concerns about Aduhelm’s rollout, including “atypical” interactions and collaboration between the FDA and Biogen; inappropriate use of th

FDA 105

FDA 105

European Pharmaceutical Review

JANUARY 17, 2023

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has granted a marketing authorisation for Ximluci ® (ranibizumab), a biosimilar referencing Lucentis®, to help treat a leading cause of blindness globally. Ximluci ® has been approved in the UK for treating wet age-related macular degeneration (wet AMD), diabetic macular oedema (DME), diabetic retinopathy (PDR), retinal vein occlusion (RVO) and visual impairment due to choroidal neovascularization (CNV) in adults.

104

104

STAT

JANUARY 17, 2023

More than two dozen big buyers of prescription medicines expect that prices will rise by an average of 8% annually over the next three years, a slight uptick from a year ago. And 19% believe that a “substantial portion” of the anticipated increases can be attributed to a shift to newer, pricier therapies, which is up from 8% a year ago, a new survey found.

Hospitals 104

Hospitals 104

Drug Store News

JANUARY 17, 2023

Texans rank pharmacies as the most accessible healthcare destination and support policies that allow patient choice when it comes to accessing services, NACDS said.

104

104